Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2001
01/18/2001WO2001004110A1 Benzimidazole compounds
01/18/2001WO2001004107A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES
01/18/2001WO2001004102A1 Quinazoline derivatives
01/18/2001WO2001003684A2 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
01/18/2001CA2379416A1 Heteroaryl protease inhibitors and diagnostic imaging agents
01/18/2001CA2379149A1 Neurotrophic pyrrolidines and piperidines, and related compositions and methods
01/18/2001CA2378291A1 Quinazoline derivatives
01/17/2001EP1069114A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
01/17/2001EP1069111A1 Indole derivatives with antiviral activity
01/17/2001EP1068304A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
01/17/2001EP1068202A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
01/17/2001EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists
01/17/2001EP1068191A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
01/17/2001EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
01/17/2001EP1068187A1 Pyrazole inhibitors of cytokine production
01/17/2001EP1068185A1 Compounds with activity on muscarinic receptors
01/17/2001EP1067894A2 Protease inhibitors
01/17/2001EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds
01/17/2001EP0730590B1 isoxazoline and isoxazole fibrinogen receptor antagonists
01/17/2001CN1280577A Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties
01/17/2001CN1280575A New tricyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
01/17/2001CN1280570A Substituted fused heterocyclic compounds
01/16/2001US6174909 For treating analgesia, psychosis, convulsions, epilepsy, anxiety, muscular and movement disorders, spastic disorders or symptoms of huntington's or parkinsons disease
01/16/2001US6174908 Treating disease, condition, or disorder which responds to inhibition of potassium channel function by administering thiazolidone or metathiazonone compound, its salt, amide, ester, complex, chelate, hydrate, stereoisomer, metabolite
01/16/2001US6174907 Therapy and prophylaxis of hyperlipemia or arterial sclerosis; as additive of a silver halide photosensitive material, liquid crystal material
01/16/2001US6174883 3-substituted-2-oxindoles derivatives
01/16/2001CA2025932C Pyrazole-3-carboxamides
01/16/2001CA2021954C Substituted triazolinones, triazolinethiones and triazolinimines as angiotensin ii antagonists
01/16/2001CA2010800C Protein labelling
01/11/2001WO2001002558A1 Probe for analysis of nucleic acids
01/11/2001WO2001002394A1 Substituted indole compounds and their use for the treatment of cancer
01/11/2001WO2001002385A1 1-(quinolin-4-yl)-1h-pyrazole derivatives and their use as fungicides
01/11/2001WO2001002379A1 Selective npy (y5) antagonists
01/11/2001WO2001002377A1 Telomerase inhibitors and methods of their use
01/11/2001WO2001002376A1 Amino-alkyl derivatives
01/11/2001WO2001002369A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
01/11/2001WO2001002356A1 Indoline or tetrahydroquinoline derivatives
01/11/2001WO2001002350A2 Novel amino sulfonamides and amido sulfonamides as antiviral agents
01/11/2001WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/11/2001CA2380866A1 Selective npy (y5) antagonists
01/11/2001CA2341253A1 Telomerase inhibitors and methods of their use
01/10/2001EP1067128A1 Fused thiophene derivatives and drugs containing the same as the active ingredient
01/10/2001EP1067109A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
01/10/2001EP1066283A2 Substituted indolealkanoic acids
01/10/2001EP1066281A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
01/10/2001EP1066272A1 Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
01/10/2001EP1066268A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists
01/10/2001EP1066267A1 Substituted phenyl uracils
01/10/2001EP1066256A1 The use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles
01/10/2001CN1279680A Imidazole derivatives with inhabiting activity to transterasa and preparing method thereof
01/10/2001CN1279674A 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders
01/10/2001CN1279673A ((Cyclo) alkyl substituted-.gamma.-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
01/10/2001CN1279670A Substituted oximes as neurokinin antagonists
01/10/2001CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
01/10/2001CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders
01/10/2001CN1279617A Combination of an aldose reductase inhibitor and a glycogen phosphorglase inhibitor
01/10/2001CN1279604A Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration.
01/10/2001CN1060479C Preparation method for inidazole derivatives
01/10/2001CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof
01/09/2001US6172261 Biosynthesis using chain extension
01/09/2001US6172095 Decongestants, analgesics, hypotensive agents; treating headaches, otitis media, sinusitus, gastrointestinal and respiratory system disorders; side effect reduction
01/09/2001US6172092 Fungicides, bactericides for crops; treating plant diseases; applying to wood, leather, plastic
01/09/2001US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/09/2001US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
01/09/2001CA2031766C 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same
01/09/2001CA2017269C Fluorogenic benzoxazoles
01/04/2001WO2001000623A1 Method of producing nitroguanidine- and nitroenamine derivatives
01/04/2001WO2001000621A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
01/04/2001WO2001000615A1 Respiratory syncytial virus replication inhibitors
01/04/2001WO2001000611A1 Respiratory syncytial virus replication inhibitors
01/04/2001WO2001000603A1 Thiazole and oxazole derivatives and their pharmaceutical use
01/04/2001WO2001000601A1 Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia
01/04/2001WO2001000600A1 N-substituted perhydro diazine
01/04/2001WO2001000598A1 N-[4-(6-oxotetrahydrotriazinyl)phenyl]amides and use thereof
01/04/2001WO2001000589A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof
01/04/2001WO2001000583A1 Ucf116 derivatives as antitumor agents
01/04/2001WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
01/04/2001WO2001000570A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
01/04/2001WO2001000229A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
01/04/2001WO2001000213A1 Src kinase inhibitor compounds
01/04/2001WO2001000188A2 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia
01/04/2001WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia
01/04/2001WO2000020358B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
01/04/2001DE19930075A1 Neue Amino- und Amidosulfonamide als antivirale Mittel New amino and Amidosulfonamide as antiviral agents
01/04/2001DE19929787A1 Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung New 4- (2-Oxodihydrooxadiazinylphenyl) amides and their use
01/04/2001DE19929785A1 Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung Tetrahydroquinolinyl-6-methyldihydrothiadiazinon derivatives and their use
01/04/2001DE19929782A1 6-Carboxyphenyldihydropyridazinon-Derivate und ihre Verwendung 6-Carboxyphenyldihydropyridazinon derivatives and their use
01/04/2001DE19929781A1 N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung N- [4- (6-Oxotetrahydrotriazinyl) phenyl] amides and their use
01/04/2001CA2383546A1 Src kinase inhibitor compounds
01/04/2001CA2377154A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
01/04/2001CA2377137A1 N-substituted perhydro diazine
01/04/2001CA2377117A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof
01/04/2001CA2376891A1 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
01/04/2001CA2376785A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
01/04/2001CA2376781A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
01/04/2001CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
01/04/2001CA2369145A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
01/03/2001EP1065205A1 Heteroaromatic derivatives
01/03/2001EP1064289A1 Heterocyclic signal transduction inhibitors, compositions containing them
01/03/2001EP1064273A2 1,3,4-thiadiazoles useful for the treatment of cmv infections